- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Postprandial Metabolic Events in Austria
Total 2203 results
-
Medical University of ViennaCompletedSecondary Hyperparathyroidism | CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder | Kidney ReplacementAustria
-
RDC Clinical Pty LtdNot yet recruiting
-
SanofiTerminatedDiabetes Mellitus, Type 2Australia
-
Baker Heart Research InstituteNational Health and Medical Research Council, Australia; Hoffmann-La Roche; Diabetes...CompletedDiabetes Mellitus, Type 2Australia
-
Resverlogix CorpSouth Australian Health and Medical Research InstituteTerminatedCoronary Artery Disease | DyslipidemiaAustralia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Germany, United Kingdom, Sweden, Switzerland
-
Eli Lilly and CompanyCompleted
-
University Hospital TuebingenMedical University of Vienna; University of Bern; CenTrial GmbHTerminatedObesity | DiabetesAustria, Germany, Switzerland
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
-
HighTide Biopharma Pty LtdCompleted
-
Green BeatMedical University of GrazCompletedInflammation | Oxidative Stress | AcidosisAustria
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
Medical University of ViennaCompletedEvaluation of Expected Bone Loss After Bariatric Surgery | Possible Prevention of Bone Loss After Surgery by Calcium and Vitamin D SupplementationAustria
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Abbott Diabetes CareCompleted
-
AstraZenecaCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Australia
-
Baker Heart Research InstituteUnknownObesity | Metabolic Syndrome | Type 2 DiabetesAustralia
-
KDL Inc.UnknownEnd Stage Renal Disease | HyperphosphatemiaAustralia
-
Medical University of ViennaVienna Dialysis CenterRecruitingDiabetes Mellitus, Type 2 | Hemodialysis | Chronic Kidney Disease | Kidney Failure | Left Ventricular HypertrophyAustria
-
Medical University of ViennaRatiopharm GmbHCompletedPreterm Delivery | Preeclampsia | Gestational Diabetes | Vitamin d Deficiency | Gestational HypertensionAustria
-
Medical University of GrazCompletedHeart Failure | Osteoporosis | Osteoporotic Fractures | Pulse Wave Analysis | Blood Pressure Monitoring, Ambulatory | ComorbidityAustria
-
MetaCure (USA), Inc.CompletedDiabetes Mellitus, Type 2Austria, Germany, Italy, Poland
-
Martin HuelsmannRecruitingHeart Diseases | Diabetes Mellitus, Type 2New Zealand, Austria, Netherlands, Spain, United Kingdom
-
AstraZenecaCompletedDiabetes Mellitus | Peripheral Vascular Diseases | Atherosclerosis | Carotid Stenosis | Hyperlipidemias | Coronary Heart DiseaseAustria
-
Carmot Therapeutics, Inc.Carmot Australia First Pty LtdRecruiting
-
SanofiCompletedDiabetes Mellitus, Type 1France, Australia, Spain, Sweden, United States, Austria, Hungary, Israel, Italy, United Kingdom, Korea, Republic of, Netherlands
-
The George InstituteNational Health and Medical Research Council, Australia; University of British... and other collaboratorsCompletedHyperglycemia | Critical IllnessAustralia
-
Resverlogix CorpNucleus Network Ltd; Baker Heart and Diabetes InstituteCompleted
-
Vaxxinity, Inc.Novotech (Australia) Pty LimitedActive, not recruiting
-
QL Biopharmaceutical Australia Pty LtdNovotech (Australia) Pty Limited; Beijing QL Biopharmaceutical Co.,LtdRecruiting
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
Medical University of GrazMedical University InnsbruckRecruitingAmyloid Cardiomyopathy | Wild Type ATTR AmyloidosisAustria
-
DiObexTerminatedType 2 DiabetesAustralia, United States, New Zealand
-
Royal Adelaide HospitalCompletedDiabetes Mellitus | GastroparesisAustralia
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, Australia, Austria, Canada, France, Greece, Italy, Japan, South Africa, Ukraine
-
Medical University of ViennaEuropean Society for Clinical Nutrition and Metabolism; Austrian Society for...Recruiting
-
Medical University of ViennaEuropean Society for Clinical Nutrition and Metabolism; Austrian Society for...Recruiting
-
Daiichi Sankyo, Inc.CompletedHypercholesterolemiaUnited States, South Africa, Israel, Netherlands, Canada, Norway, Austria, Australia
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Austria, Germany, United States
-
Bayside HealthBaker Heart Research Institute; International Diabetes Institute, AustraliaTerminated
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
University of AdelaideRoyal Adelaide HospitalCompletedInsulin Resistance | Diabetes Mellitus, Type IIAustralia
-
Zealand PharmaCompletedHypoglycemia | Diabetes Mellitus, Type 1Canada, United States, Austria, Germany
-
Menzies School of Health ResearchWithdrawn
-
Genzyme, a Sanofi CompanyTerminatedFabry Disease | Alpha Galactosidase A DeficiencyUnited States, Austria, United Kingdom
-
Nemysis LtdRDC Clinical Pty LtdRecruitingIron-deficiencyAustralia
-
Menzies Institute for Medical ResearchRecruiting
-
GlaxoSmithKlineTerminated